Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDX3X | O00571 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 8/20 | 0.37 |
| ▸ | ACHE | P22303 | 2/20 | 0.37 |
| ▸ | NAMPT | P43490 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | NEU4 | Q8WWR8 | 1/20 | 0.35 |
| ▸ | NEU3 | Q9UQ49 | 1/20 | 0.35 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12640254 | 0.82 | HDAC1 (0.46) | DDX3XHDAC1CSNK2A1 | |
| SCHEMBL18289680 | 0.82 | CYP19A1 (0.41) | DDX3XHDAC1FFAR1CSNK2A1 | |
| SCHEMBL24247412 | 0.81 | FFAR1 (0.39) | DDX3XHDAC1FFAR1CSNK2A1 | |
| SCHEMBL24713570 | 0.80 | POLB (0.43) | ACHENAMPTNEU4NEU3 | |
| SCHEMBL17490608 | 0.79 | EPHX2 (0.46) | HDAC1CSNK2A1 | |
| SCHEMBL17776274 | 0.79 | EPHX2 (0.46) | HDAC1CSNK2A1 | |
| SCHEMBL25892147 | 0.78 | HDAC1 (0.45) | HDAC1CSNK2A1 | |
| SCHEMBL13925909 | 0.78 | DDX3X (0.39) | DDX3X | |
| SCHEMBL18618632 | 0.78 | CYP19A1 (0.54) | — | |
| SCHEMBL13437065 | 0.78 | FOLH1 (0.46) | DDX3XHDAC1CSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12036319-B2 | Polyvalent sting activating compositions and uses thereof | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12036319-B2 | Polyvalent sting activating compositions and uses thereof | STING1, CGAS, TLR7 | DDX3X 459/4885HDAC1 4686/4885ACHE 4280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.